Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Rinucumab [USAN]
RN: 1569263-06-4

Molecular Formula

  • C6472-H9974-N1710-O2022-S38 (peptide)

Classification Code

  • Treatment of Neovascular Age-Related Macular Degeneration
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Rinucumab [USAN]


  • Immunoglobulin G4-kappa, anti-(human platelet-derived growth factor receptor b (CD140 antigen-like family member B, PDGFR-1, CD140b)); human monoclonal antibody; g4 heavy chain (1-448) (human VH (IGHV4-39*01-(IGHD)-IGHJ5*02) (93%) (10.7.14) (1-122)-IGHG4*01 (CH1 (123-220), hinge S230>P230 (221-232), CH2 (233-342), CH3 (343-448)) (123-448))(136-215')-disulfide with kappa light chain (1'-215') (human V-KAPPA (IGKV3-20*01-IGKJ3*01) (92%) (7.3.9)(1'-108')-IGKC*01 (109'-215')) dimer (226-226'':229-229'')-bisdisulfide
  • REGN2176
  • Rinucumab
  • UNII-10E3O6YI4W

Systematic Name

  • Immunoglobulin G4, anti-(human platelet-derived growth factor receptor beta) (human monoclonal REGN2176 heavy chain), disulfide with human monoclonal REGN2176 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 1569263-06-4


  • 10E3O6YI4W

System Generated Number

  • 1569263064